Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Surgery Partners, Inc. Director's Dealing 2023

Mar 6, 2023

31430_dirs_2023-03-06_f5f66736-a814-43fb-aca9-dc75d53ed598.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Surgery Partners, Inc. (SGRY)
CIK: 0001638833
Period of Report: 2023-03-02

Reporting Person: Doherty David T (Chief Financial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-03-02 Common Stock A 21302 $32.86 Acquired 72677 Direct
2023-03-02 Common Stock A 30432 $32.86 Acquired 103109 Direct
2023-03-03 Common Stock S 20000 $33.98 Disposed 83109 Direct

Footnotes

F1: Shares will vest in three equal annual installments of each of the first three anniversaries of March 2, 2023.

F2: Shares will all vest on the third anniversary of March 2, 2023.

F3: The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.